Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213

EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.

Howard E. Skipper, F. M. Schabel, W. S. Wilcox · PubMed · 1964 · 766 citations

Medicine, Oncology, Pharmacology +12

Central Nervous System Therapy and Combination Chemotherapy of Childhood Lymphocytic Leukemia

Rhomes J. A. Aur, Joseph V. Simone, H. Omar Hustu et al. · Blood · 1971 · 359 citations · Full text

Medicine, Oncology, Pediatrics +14

Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors

H. Stähblin · European Journal of Cancer (1965) · 1973 · 183 citations

Medicine, Medicinal Chemistry, Pharmacology +6

4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action

H. Stähelin · European Journal of Cancer (1965) · 1970 · 129 citations

Life Sciences, Botany, Medicinal Chemistry +7

Evidence That Drugs in Multiple Combinations Have Materially Advanced the Treatment of Human Malignancies

Edward S. Henderson, Richard J. Samaha · Cancer Research · 1969 · 114 citations

Medicine, Oncology, Pharmacology +11